Topical UV Filter Composition for Safe Home Phototherapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current phototherapy methods for conditions like psoriasis and acne require frequent clinic visits and are limited by high co-pays and compliance issues due to time commitment, with existing portable lamps posing safety risks from non-therapeutic UV radiation exposure.

Innovation Solution

Development of a topical composition that selectively filters electromagnetic radiation, allowing preferential delivery of therapeutic wavelengths while blocking harmful UVB and UVA radiation, using compounds like hesperidin and cinnamates, and a method to calculate and control exposure using digital devices for safe and convenient at-home treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If NB-UVB phototherapy is administered at medical offices using artificial light sources, then therapeutic effectiveness is improved, but harmful non-therapeutic UVB radiation exposure increases

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidharmful UVB radiation exposure
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces a topical composition containing UV-filtering compounds (such as cinnamates, benzophenones, or avobenzone) as an intermediary layer between the skin and the NB-UVB light source. This intermediary selectively blocks harmful non-therapeutic UVB wavelengths (below 305 nm) while allowing therapeutic wavelengths (305-320 nm) to penetrate, thereby resolving the contradiction between therapeutic effectiveness and harmful radiation exposure

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent applies the concept of local quality by creating a wavelength-selective filter with different transmission properties at different wavelengths. The topical composition has high absorption coefficient for harmful UVB wavelengths and low absorption coefficient for therapeutic wavelengths, enabling selective protection at the skin surface while maintaining therapeutic efficacy

Inventive Principle:
Principle #3Local quality

2Reliability

If phototherapy requires frequent clinic visits two to three times a week for three months, then treatment effectiveness is improved, but patient compliance and accessibility deteriorate

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidpatient compliance
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent enables patients to perform phototherapy at home using portable UV lamps and a specially formulated topical composition. The topical agent serves as a safety mechanism that allows patients to self-administer treatment without requiring medical supervision, while the wavelength-selective filtering ensures safe and effective therapy, thereby dramatically improving compliance and accessibility

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent requires patients to apply the topical composition before each phototherapy session as a preliminary protective action. This preliminary application of the wavelength-selective filter ensures that harmful radiation is blocked before exposure begins, allowing safe home-based treatment and reducing the need for frequent clinic visits

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If portable phototherapy lamps are used at home, then patient convenience is improved, but safety deteriorates due to difficulty in administering proper dosage and exposure to harmful radiation

Engineering Contradiction:
Improvepatient convenienceVSAvoidsafety
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The topical composition acts as a safety intermediary that patients can easily apply at home. It provides built-in wavelength selectivity, automatically filtering harmful radiation while allowing therapeutic radiation through, eliminating the need for patients to manually control dosage parameters and ensuring safe treatment even with portable lamps

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the physical-chemical parameters of the radiation by using topical compounds with specific absorption spectra. The composition modifies the wavelength distribution of UV radiation reaching the skin, absorbing harmful wavelengths and transmitting therapeutic wavelengths, thereby transforming an unsafe treatment into a safe one while maintaining convenience

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances patient safety and convenience by allowing controlled, effective phototherapy at home, reducing harmful radiation exposure and improving compliance through targeted UV delivery, thereby improving treatment outcomes for dermatological conditions.

Implementation Method 1

a compound, suitable for application to human skin, which may block substantially more UVB light at wavelengths below about 310 nm than at wavelengths above about 310 nm

Methodology Applied
Scientific EffectSelective absorption of electromagnetic radiation: Absorption (EM radiation)

Data Source

PatentUS10111821B2Methods and compositions for administering a specific wavelength phototherapy
Publication Date: 2018.10.30 JUPITER WELLNESS INC
  • US10111821B2 patent drawing
  • US10111821B2 patent drawing
  • US10111821B2 patent drawing

AI summary

Methods are disclosed for administering electromagnetic radiation (EMR), which may include filtering EMR from part of the EMR spectrum while allowing passage of EMR at a desired wavelength range. Uses may include the treatment of such conditions as psoriasis, vitiligo, pruritus, acne, vitamin-D deficiency and atopic dermatitis. Topical creams, sprays, or other compositions may be used, with or without dosimeters, or in conjunction with an application, which calculates local UV exposure and other factors relating to dosage.